Orthopaedics and Musculoskeletal Podcasts

Orthopaedics Podcasts on Health Podcast Network

Latest Episodes

#30 Running for Congress as an Orthopaedic Surgeon

In this episode, AAOS Advocacy Council Chair and podcast host Douglas Lundy, MD, MBA, FAAOS sits down with Al Olszewski, MD, FAAOS (R-MT) to discuss his 2022 campaign for Congress. They discuss Dr. Al’s path to politics, why it’s important for orthopaedic surgeons to be involved politically, and how politicians can work together in the best interest of patients. Dr. Al's primary is on June 7. Additional links and resources:  AAOS Now Article about Dr. Olszewski’s Campaign: AAOS Press Release Endorsement of Dr. Olszewski: AAOS OrthoPAC: Guest: Al Olszewski, MD, FAAOS, Candidate for U.S. Congress Host: Douglas Lundy, MD, MBA, FAAOS, AAOS Advocacy Council Chair
May 17, 2022
Play now

#8 Influencer Series Part 1: Giving Back to Student Athletes — Dr. Keith Feder, 2022 AAOS Humanitarian Award winner

An athlete who became an orthopaedic surgeon, Keith Feder, MD, FAAOS, recognized during his residency the gap in orthopaedic care for high school student athletes in underserved communities. Practicing in California, he offered free sports medicine care to student athletes at inner city schools before he founded the West Coast Sports Medicine Foundation in 1994. Dr. Feder, as the 2022 AAOS Humanitarian Award winner, shares the programs and philosophy his foundation follows to help more than 13,000 student athletes each year.  Guest: Keith S. Feder, MD, FAAOS, 2022 AAOS Humanitarian Award winner Host: Liana J. Tedesco, MD, Chair, AAOS Resident Assembly 
May 3, 2022
Play now

#4 – Fighting sepsis with nanoengineered beads to filter the blood – Lukas Langenegger – Hemotune

One consequence of the covid-19 crisis we are still going through is sepsis, a lethal misguided reaction of the immune system following an infection, currently responsible for 11 million deaths yearly on a global scale. Together with his team, Lukas Langenegger is addressing this life-threatening condition using a unique technology leveraging magnetic microscopic beads that enable the filtration of blood and the removal of toxic compounds circulating through the body during such a medical episode. The so-called Hemosystem is akin to a dialysis machine where the traditional membrane filter is replaced by a solution containing these beads. Offering a very large surface area, they are used to selectively trap key toxic compounds known to contribute to sepsis: their removal enables in fact to reestablish the immune balance of the patient, leading to drastically improved outcomes. This disruptive technology has been rewarded and praised multiple times in the Swiss medtech sphere and the media. Lukas himself has already been featured in the German issue of Forbes, as a recognition for the pioneering work and contribution that he and his team are bringing in the fight against this terrible condition. We exchanged with Lukas on his professional path, which started in the world of banking before moving towards chemical engineering and the start of a PhD, which he interrupted after a few months to embrace the entrepreneurial route. He guides us with passion through the genesis of Hemotune, the functioning of the system they have created and the surprising development perspectives that such a platform could allow, from the treatment of cancer up to the extension of our longevity! Timeline: (01:05) - Introduction to Lukas’ background and the origins of Hemotune (02:12) - Transitioning from banking to chemical engineering (04:59) - Quitting a PhD to become an entrepreneur (07:34) - Bringing multiple specialties together to found Hemotune (08:58) - Finding support from the Swiss ecosystem to kick start your own firm (09:49) - Hemotune’s technology and its first indication: sepsis (11:17) - Understanding the mechanisms of sepsis and the lack of current recovery treatment (14:20) - Timing of the intervention for patients using the Hemosystem (15:01) - Current standard of care and keeping patients suffering from sepsis alive (16:22) - Reestablishing the immune balance thanks to the Hemosystem (18:10) - Towards magnetic microscopic beads tailored to each patient (19:56) - The Hemosystem workflow and blood filtering cycles (20:57) - Engineering the magnetic microscopic beads (22:30) - Preventing toxicity from the beads towards the blood (26:00) - The development roadmap of the Hemosystem and its foreseen availability (30:18) - Moving towards other indications (e.g. cancer, autoimmune diseases, longevity) (32:02) - Establishing a new treatment modality at the interface of a drug and a medical device (33:15) - Addressing the burden of antimicrobial resistance What we also talked about with Lukas : Carlos Andrea Mora Corinne Hofer Precision Medicine ETHZ MIT Functional Materials Laboratory from Prof. Wendelin Stark HLA-DR Kurz Gesagt Immune: A Journey into the Mysterious System That Keeps You Alive Leo Grünstein Spiden If you want to know more about Hemotune, we invite you to consult their website: We also invite you to follow their activities on LinkedIn or through their newsletter (subscription link available through the company website). You can contact Lukas through LinkedIn or by email: [email protected] If you want to give me feedback on the episode, ask questions or suggest potential guests, feel free to do so through LinkedIn or by email: [email protected]
May 1, 2022
Play now

Five Evidence-Based Strategies For Losing Weight

With summer right around the corner, it’s quite common for people to focus on shedding a few pounds. While many diets and fads have some merit, today we’re going to talk about five simple, science-based weight loss strategies that can help you slim down before summer. These include: tracking your diet and exercise daily, starting your day with protein, intermittent fasting, balancing your gut bacteria, and of course, reducing your intake of sugar and refined carbs.
April 29, 2022
Play now

#29 Consolidation Part III: Impact of Consolidation on Musculoskeletal Care

In this episode, Dr. Lundy interviews three AAOS members who have different perspectives on the role of consolidation in the advancement of musculoskeletal care. Listeners will hear from them on the pros and cons of consolidation and learn more about how consolidation will influence future trends in the practice of orthopaedic surgery.  Additional links and resources: Podcast episode on "Repeal of Antitrust Exemption for Health Insurers": FAQ on consolidation: AAOS Advocacy Action Center: Guests: James W. Barber, M.D., Southeastern Orthopaedics; Frederic E. Liss, M.D., Rothman Orthopaedic Institute; Ronald A. Navarro, M.D., Kaiser Permanente  Host: Douglas Lundy, M.D., MBA, FAAOS, AAOS Advocacy Council Chair
April 19, 2022
Play now

The Evolution of Cartilage Restoration with Guest Solomon Wilcots

Dr. Brian Cole is joined by former NFL safety and broadcaster Solomon Wilcots to discuss advancements in cartilage restoration.
April 11, 2022
Play now

#7 Introducing our New Hosts and Resident Assembly Initiatives in 2022

In his final episode as host, Dr. Austin Beason introduces the new co-hosts of the Career Podcast-- new AAOS Resident Assembly chair Dr. Liana Tedesco and vice-chair Dr. Daniel Cognetti. Together they talk about some exciting initiatives coming to the Resident Assembly (RA) this year and the value of getting involved now! The RA is an advisory body to the AAOS on issues of importance to orthopaedic residents and empowers residents to embrace their roles as patient advocates and life-long learners.  This episode was recorded live at the AAOS Annual Meeting in Chicago, which took place from March 222-26.  Contact the Resident Assembly: [email protected] Learn more about getting involved with the Resident Assembly: Guests: Liana Tedesco, MD, Chair AAOS Resident Assembly and Daniel Cognetti, MD, Vice Chair, AAOS Resident Assembly Host: Austin Beason, MD, Past Chair, AAOS Resident Assembly
April 5, 2022
Play now

How To Create Healthy Lifestyle Habits with Karen Malkin

Dr. Brian Cole is joined by Karen Malkin from Karen Malkin Health Consulting to talk about the best ways to create healthy lifestyle habits.
March 31, 2022
Play now

To the Future and Beyond! Exploring the OR of Tomorrow with Panelists Danny Goel, MD; Kris Siemionow, MD, PhD; Ken Trauner, MD & Richard Angelo, MD, PhD

Join DocSF co-chair Ashley Libby Diaz in this wonderful panel discussion with the best in the industry.  We are joined by Dr. Kris Siemionow, the CMO of Surgalign, Dr. Ken Trauner, founder of, Dr. Rick Angelo, CMO at Kaliber.AI, and Danny Goel, M.D., CEO and co-founder of PrecisionOS, in this great conversation about the OR of the future. These doctors share their thoughts, from what they imagine these rooms will be like in the future to what technology they will be using. Data collection from the OR, Artificial Intelligence and Augmented Reality, ambulatory options for patients, and robotics around ortho and the MSK space are topics they go through. In this discussion panel, we uncover the future that it’s just around the corner and will help surgeons be better equipped to help more patients.  Join the revolution, start with these episodes and join us at DocSF22. REGISTER NOW to DOCSF The Experience 2022
March 31, 2022
Play now

#3 – Augmenting the lives of paraplegics with exoskeletons – Tristan Vouga – Twiice

Wearables bringing back the ability to walk for paraplegics: this is the world in which Tristan Vouga is evolving. Passionate by the field of robotics and willing to have an impact on society, he turned his PhD thesis into the Swiss startup Twiice. The company is developing a modular exoskeleton, bringing back the ability for its users to stand, walk, climb stairs and even go on a ski tour! Beyond the technological achievement and the numerous awards it has won in international contests, their platform has the potential to transform the lives of many paraplegics as well as amputees. We talked with Tristan about his transition from PhD student to entrepreneur, about their exoskeleton capabilities, the feelings of “ownership, embodiement and agency” that are key to a seamless human-machine interaction, and about how innovation can be derived from science-fiction! Timeline: (01:44): Tristan’s introduction and background in wearable robotics (03:22): Moving to the US to explore brain-controlled exoskeletons (08:10): Description of the exoskeleton Twiice, how it operates and supports paraplegics (10:52): The importance of embodiment, ownership and agency in human-machine interactions (12:42): Leveraging brain signals to control wearable exoskeletons (14:03): Generating haptic feedback to enhance the feelings of ownership, embodiment and agency (15:57): Developing an exoskeleton for ski touring (18:38): Exploring new use cases for amputees (21:01): Innovative commercial models to distribute the cost of ownership among patients (22:59): A clinical trial to demonstrate the efficacy and safety of Twiice in a community setting (24:29): Seamless human-machine interaction as a key differentiator (26:16): Moving towards an exoskeleton not requiring crutches (30:20): The Cybathlon and competing against other exoskeletons (35:02): Dealing with the frustration of access hurdles for patients (36:11): Coping with the demand from patients while driving R&D efforts (38:17): Transitioning from PhD student to entrepreneur (40:18): Drawing inspiration from science-fiction What we also talked about with Tristan: EPFL ETHZ Duke University ReHassist The Nicolelis Lab Neuralink The triad: embodiment-ownership-agency Boston Dynamics The Cybathlon The Global Innovation Challenge Blade Runner Testmate Health We cited with Tristan some of the past episodes from the podcast: #1 - Measuring your arterial age to prevent heart diseases - Ted Baldwin - Imageens
March 30, 2022
Play now

What is Enterprise Blockchain? How is it Used?

This episode is all about what enterprise blockchain is and how it can be used! We are honored to feature Radhika Inyegar, co-author of the book “Enterprise Blockchain Has Arrived”. She shares with us how the blockchain came about conceptually, the differences between proof of work versus proof of stake, the different roles for permission and permission-less systems, smart contracts and the impact it will have on healthcare. Blockchain is essentially a database that has multiple owners, so everyone sees and has access to the same information. Right now, blockchain is used in the non-PHI side of healthcare.  Blockchain is all about truth and transparency in the transactions involved, and their application to healthcare is going to change the game.  About Rhadika Inyegar Radhika Iyengar is a TEDx and keynote speaker, author, Silicon Valley Woman of Influence, and a serial entrepreneur. She is Founding Partner at StarChain Ventures, a Silicon Valley-based venture studio focused on the convergence of advanced technologies including Blockchain, AI and IoT. She is also Managing Partner of DoubleNova Group, a global advanced tech advisory company based in Silicon Valley. Radhika is a co-author of the critically acclaimed book Enterprise Blockchain Has Arrived. As an enterprise blockchain expert, she has advised companies globally in the healthcare, fintech and supply chain sectors. She is a member of the Government Blockchain Association as well as the California Gov Ops Blockchain Working Group, a task force advising California state legislature, where she has advised on a wide range of areas such as healthcare, life sciences and pharma supply chains, digital identity, privacy, sustainability, and food and agriculture supply chains. Radhika is an Advisory Board Member and Global Ambassador of Blockchain in Healthcare Today (BHTY), the world’s first peer-reviewed journal on blockchain in healthcare. Key Take-aways  The Internet changed the world, and blockchain is on its way to do the same.  Blockchain is a distributed ledger technology which allows multiple owners to have ownership of the data that's within it. Once a change is made in a blockchain, it is immutable.  In blockchain all of the blocks of information are tied to each other.  Blockchain does not store data, it stores the hash of the record.  Guest Links and Resources: Connect and Follow Radhika on LinkedIn:  Follow Radhika on Twitter:  Grab your copy of the book “Enterprise Blockchain Has Arrived” by Radhika Inyegar and Jorden Woods here: 
March 30, 2022
Play now

Investment Trends in Musculoskeletal Digital Technologies: Unpacking the Trends

We are joined by Robin Young, the CEO of PearlDiver, on the DocSF Venture virtual stage for this episode.  Robin has been in the orthopedics ecosystem for the last 35 years, has a background in Wall Street, is a publisher of the Orthopedics This Week Magazine, and is a renowned writer. He is here on DocSF Venture to help us understand how to read and understand capital data from the industry. The Medtech field, specifically in orthopedics, has gotten a lot of investment since 2018, and the numbers show it. Robin talks to us about how the orthopedic companies know their future lies in the digital field, how other industries like sports and gaming are helping orthopedics and what AI brings to the landscape.  If you are interested in the digital space and new Medtech processes, listen to this conversation and enjoy! REGISTER NOW to DOCSF The Experience 2022
March 29, 2022
Play now

What’s Hot? Where’s the Money Going? with Dr. Nancy Lynch

In this episode of the DocSF podcast, you are greeted by Dr. Nancy Lynch, President of Advisorthopædics, as she kicks off the event. We start with a very insightful presentation by Dr. Lynch, in which she presents a lot of data regarding the musculoskeletal digital health space in terms of investment. There is a lot of money flowing into the industry, and we need to understand how innovation and investment are working right now. Nancy walks us through how these investments are cross-pollinating from other fields in the health sector but ultimately lead to the MSK space. She also does a great emphasis on where the money is going.  With the field settled, we are ready to move on to Robin Young’s conversation in the next episode. Tune in and join the revolution! REGISTER NOW to DOCSF The Experience 2022
March 24, 2022
Play now

How Sports Psychology Helps Athletes and Performers with Lauren Loberg, PhD

On this episode of Sports Medicine Weekly, Dr. Lauren Loberg joins Dr. Brian Cole to discuss her experiences as a UCLA student-athlete, coach, researcher, mental health counselor, and sports psychology consultant.
March 21, 2022
Play now

#28 Consolidation Part II: Federal and Industry Response

This second episode in our series on consolidation in healthcare centers around the Federal Trade Commission's (FTC) role of enforcing the nation's antitrust laws and ensuring competition within the industry. Special guest Mark D. Seidman, Assistant Director for the Mergers IV Division at the FTC, explains how the agency investigates mergers and their impact on the future of healthcare delivery.  Guest: Mark D. Seidman, Assistant Director for the Mergers IV Division at the Federal Trade Commission Host: Douglas Lundy, MD, MBA, FAAOS, AAOS Advocacy Council Chair 
March 15, 2022
Play now

The Best Treatments For Patellar Tendonitis

Josh James, a Physical Therapist from RUSH PT joins Dr. Cole to discuss the best ways to manage patellar tendonitis, commonly referred to as jumper's knee.
March 7, 2022
Play now

#6 Becoming a Leader Through the Academy’s ALI

This episode, featuring AAOS Past President Joseph A. Bosco III, MD, FAAOS, explains how leadership is tied to professional development and propelling one’s career with a focus on the AAOS Leadership Institute (ALI). The exclusive program for AAOS members provides training, mentoring, and networking opportunities for acquiring and enhancing the key skills needed to succeed both as a volunteer leader at AAOS and in general as an orthopaedic surgeon. Dr. Bosco offers lessons learned from guiding AAOS through the COVID-19 pandemic and helpful advice for members with an eye on Academy leadership. Learn more about the AAOS Leadership Institute (ALI): Guest: Joseph A. Bosco III, MD, FAAOS, Past President, AAOS Host: Austin M. Beason, MD, Chair, AAOS Resident Assembly
March 1, 2022
Play now

#2 – Treating liver cancer with surgical robotics – Lucien Blondel – Quantum Surgical

Lucien Blondel is one of the leading figures in the field of surgical robotics, having already led the development of several platforms supporting orthopaedic, spinal and brain surgeries. Together with Quantum Surgical, which he co-founded alongside Bertin Nahum, Fernand Badano and Sophie Roca, they are addressing liver cancer through a new robotic platform supporting ablation procedures. Under the name of “Epione” (the goddess of care in the Greek mythology), it represents a breakthrough in this field, not only supporting surgeons in the execution of the ablation procedure, but also in the planning phase up to the validation of the surgical act. Through a combination of cutting-edge image processing technology, computer vision and haptics, Epione is on its way to revolutionize interventional oncology and improve access to liver cancer ablation, for patients and for surgeons. We exchanged with Lucien on his background, what brought him to surgical robotics, the specificities of this field, his role in leading the technical development of Epione, and its underlying promise in the cure of liver cancer. Timeline: 02:09 - 04:11: Lucien’s introduction and background in surgical robotics 04:51 - 07:04: How he got into this field and what drove his interest to it 07:43 - 13:25: The uprising of surgical robotics and key developments over the past years 14:16 - 19:36: Identifying the right disease area and type of intervention 20:02 - 22:15: The type of cancer targeted by Epione and the surgical act it complements 22:49 - 24:53: Enabling percutaneous ablation beyond interventional radiologists 25:02 - 26:37: Applications of Epione beyond liver cancer 27:20 - 32:22: Epione’s components and workflow 32:51 - 35:13: Synchronizing the patient’s breathing to the robotic arm positioning 35:43 - 38:06: Synergies between Epione and other platforms previously developed by Lucien and his team 38:22 - 40:56: Moving towards fully autonomous surgical interventions 41:20 - 42:22: The meaning behind “Epione” 43:11 - 45:21: Suggested resources to dig deeper into surgical robotics 45:34 - 47:55: The “Why” What we also talked about with Lucien: ROSA Epione Mako Robotic-Arm Assisted Surgery Versius Surgical Robotic System Da Vinci Surgical Systems ExcelsiusGPS Gustave Roussy Institute Mayo Clinic The International Journal of Medical Robotics and Computer Assisted Surgery If you want to know more about Quantum Surgical, we invite you to consult their website: You can contact Lucien through LinkedIn or by email: [email protected] If you want to give me feedback on the episode, ask questions or suggest potential guests, feel free to do so through LinkedIn or by email: [email protected]
February 28, 2022
Play now

Intermittent Fasting: Fad or Fact?

Dr. Cole breaks down the science behind Intermittent Fasting (IF), discussing the potential benefits and side effects, and looking at the different types of IF plans.
February 22, 2022
Play now

#27 Consolidation in Healthcare: Trends, Impact & Outlook

The consolidation of hospitals, practices, and the healthcare market in general is a hot button issue which remains ever-present for orthopaedic surgeons. AAOS Advocacy Council Chair and podcast host Douglas Lundy, MD, MBA, FAAOS explores the trend and its impact on musculoskeletal care from various angles in this three-part series. In Part 1 with health policy analyst Brian Miller, MD, MBA, MPH, they identify the pros and cons of consolidation and how the federal government is handling potential downsides.  Additional links and resources:  Health Affairs article on the topic from Drs. Brian Miller, MD, MBA, MPH, and James Ficke, MD, FAAOS: Podcast episode on “Lifting Restrictions on Physician-Owned Hospitals”: AAOS Advocacy Action Center: Guest: Brian Miller, MD, MBA, MPH, Hospitalist and Assistant Professor, Johns Hopkins University School of Medicine Host: Douglas Lundy, MD, MBA, FAAOS, AAOS Advocacy Council Chair 
February 15, 2022
Play now

What is Synthetic Data? How Can it be Applied in Healthcare?

What are the real-world applications for synthetic data? What power can it have? And... what is it exactly? All of these questions and more are solved in this episode, featuring Dr. Michael Lesh, the CEO and founder of Syntegra. During his career he has always found ways to solve needs through technology, and that is what he and his team’s been doing with synthetic data. Starting by its definition, Michael walks us through how synthetic data could solve a lot of issues regarding privacy around medical records. In the end, synthetic data is a set of information that looks like the original but doesn’t have any patient information that could violate any restriction in place. Synthetic datasets could be solving a lot of problems in the healthcare setting that rise up when partnerships are trying to be made.  Even if you’re not a math geek, we know you will find this episode appealing; tune in and enjoy!  About Michael Lesh Michael D. Lesh, SM MD FACC, is the founder and CEO of Syntegra and an Adjunct Professor of Medicine at the University of California, San Francisco. Until recently, he also served as Executive Director of Health Technology Innovation in the Office of Vice Chancellor there. Dr. Lesh combines a background in biomedical engineering and computer science from MIT with a career as a physician-scientist in cardiac electrophysiology. He received training at UCSF and University of Pennsylvania. Dr. Lesh is an accomplished inventor and entrepreneur, having founded and served as CEO of a number of successful medical device companies, including Atrionix, Mitralife, Appriva Medical, Evera Medical and Middle Peak Medical, many of which were later acquired by leading life sciences companies. He also served as a director at HeartScape, Stentys, Abate, Cordance and KidneyCor. Dr. Lesh has authored over 200 scientific papers, book chapters and books, and he is an inventor on over 250 patents, including the foundational method of atrial fibrillation ablation and left atrial appendage occlusion to prevent stroke. Key Take-aways  Medical data has a lot of mandatory restrictions and privacy concerns. Synthetic data intends to solve a problem regarding privacy inquiries with sharing.  De-identified data is very different from synthetic data.  Once you create a synthetic data set you can augment it easily.  A generative model will fill in missing data in the sets.  Guest Links and Resources: Connect and Follow Michael on LinkedIn:  Learn more about here: 
February 15, 2022
Play now

What are Chatbots? And how can Chatbots be Used in Healthcare?

Today, we feature Manav Sevak, co-founder and CEO of Memora Health, a company that uses chatbots to help with the very complex task of sharing information between healthcare providers and their patients, or even healthcare systems. Healthcare is one of the most complex industries out there, with tons of information being transferred by the second. Chatbots are here to help this information be transferred easier between patients, providers and systems. He also walks us through how they use a decision tree.  Chatbots are changing the world and their application into healthcare is growing by the day. Tune in to this amazing episode with Mr. Sevak, you will enjoy it.  About Manav Sevak Co-Founder & CEO of Memora Health, a health company using natural language processing technology to build the next-generation of outpatient care and modernize patient communication. He is interested in everything from health tech to computational biology to health policy. Key Take-aways  The chatbot application on healthcare can improve patient access to information and resources. Chatbots are automated systems that allow for some form of interaction asynchronously to take place. Chatbots have one answer for one question only.  Chatbots can use incredibly complex decision trees according to the way they are built.  Any conversational system at the end of the day is really only as good as the data that you give it. Guest Links and Resources: Connect and Follow Manav on LinkedIn:  Follow Manav on Twitter:  Know more about Memora Health on their website: 
February 8, 2022
Play now

What Is Heart Rate Variability?

Dr. Brian Cole explains why a measurement called Heart rate variability, or HRV, is an important metric for determining your body’s readiness to perform.
February 7, 2022
Play now

#1 – Measuring your arterial age to prevent heart diseases – Ted Baldwin – Imageens

Cardiovascular diseases represent the leading cause of deaths worldwide. Despite the permanent progress in the treatment of such conditions, targeted prevention approaches remain a key solution to address this issue. This is the challenge that Imageens, a Paris-based startup led by Ted Baldwin, is tackling through the application of artificial intelligence to medical imaging, with the aim to quantify your arterial age. This specific biomarker unvails unique opportunities to anticipate heart conditions for people at moderate risk, with the promise to inform better clinical care decisions. We exchanged with Ted on the burden that cardiovascular diseases represent on a global level, the power of AI applied to medical imaging to discover early indicators of these pathologies, and how these insights can drive better personalized prevention programs to stay away from them. Timeline: 01:50 - 05:18: origins of Imageens 06:23 - 08:16: unmet need that Imageens is addressing 08:53 - 12:56: existing cardiac risk scores and the arterial age concept 13:10 - 15:36: technical approach to quantify the arterial age using MRI and AI 15:41 - 20:10: relationship between biological and arterial ages 20:32 - 22:56: MESA trial led by Johns Hopkins University and its link to the discovery of cardiac risk scores 23:26 - 30:09: Imageens softwares Artfun+ and LABEL, their functioning and role in predictive imaging biomarkers discovery 30:21 - 31:05: moving beyond MRI to other imaging modalities 31:35 - 33:21: target patient population and access to Imageens technology 33:43 - 36:09: acceptance by physicians and the medical community 36:48 - 37:30: patient journey description 38:00 - 40:24: moving towards predictive analysis of the optimal cardiac prevention program What we also talked with Ted about: Assistance Publique - Hôpitaux de Paris (AP-HP) MESA trial Framingham risk score Cardiac CT calcium score Ascending aortic distensibility Ted’s TEDx presentation Ganymed Robotics Zoï Altos Labs Qualitiso If you want to know more about Imageens, we invite you to consult their website: You can contact Ted through LinkedIn or by email: [email protected] If you want to give me feedback on the episode, ask questions or suggest potential guests, feel free to do so through LinkedIn or by email: [email protected]
February 2, 2022
Play now

Join our community and never miss
your favorite episodes

Join Our Newsletter

Proudly supported by:

Burnout or Burndown? How to Support Health Professionals